NCT06439069View on ClinicalTrials.gov

BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients

RecruitingOBSERVATIONAL
Enrollment

340

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

December 1, 2024

Conditions
Heart FailureObesity
Trial Locations (1)

LT-50161

RECRUITING

Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas

All Listed Sponsors
collaborator

Sligo General Hospital

OTHER

collaborator

KlaipÄ-da University

UNKNOWN

lead

Lithuanian University of Health Sciences

OTHER